Consultation and peer review for the division of risk assessment and prioritization
Active Definitive Contract Awarded
- Contract number
- 75F40126C00062
- Awardee
-
Versar, Inc. UEI KTERFRZBVP66
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $693,828
Award facts
- Contract value 100% obligated
- $693,827.74 Current and potential, with all options
- Completion date 28% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a definitive contract to Versar, Inc. for consultation and peer review services supporting the Division of Risk Assessment and Prioritization, with a ceiling value of $693,827.74 and an award date of July 13, 2026.
Place of performance is Silver Spring, MD. The contract is firm fixed price with an ultimate completion date of July 12, 2027.
Quick answers
Who was awarded contract 75F40126C00062?
75F40126C00062 was awarded to Versar, Inc. by Food and Drug Administration (Department of Health and Human Services) on July 13, 2026.
How much is contract 75F40126C00062 worth?
The government has obligated $693,828 on 75F40126C00062.
Was contract 75F40126C00062 competed?
The extent of competition for 75F40126C00062 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award